LifeSteps Financial’s Lexicon Pharmaceuticals LXRX Stock Holding History

LifeSteps Financial’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-10,000	Closed	-$15.7K	–	85
2024 Q3	$15.7K	Hold	10,000	–	–	0.01%	85
2024 Q2	$16.8K	Hold	10,000	–	–	0.01%	81
2024 Q1	$24K	Hold	10,000	–	–	0.02%	212
2023 Q4	$15.3K	Hold	10,000	–	–	0.01%	82
2023 Q3	$10.9K	Hold	10,000	–	–	0.01%	72
2023 Q2	$22.9K	Buy	+10,000	New	+$26.5K	0.02%	72

Other funds holding LXRX

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LifeSteps Financial's LXRX Position: Q4 2024 in Review

LifeSteps Financial sold out of Lexicon Pharmaceuticals (LXRX) in Q4 2024, closing a stake of 10,000 shares — an estimated $15.7K sold.

LifeSteps Financial first reported a position in LXRX in Q2 2023 and held it in 6 quarters. The position peaked at $24K in Q1 2024. 127 funds tracked by Wall St. Rank hold LXRX as of Q4 2024.

LifeSteps Financial reported no remaining Lexicon Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
LifeSteps Financial sold 10,000 Lexicon Pharmaceuticals shares in Q4 2024, an estimated $15.7K.
LifeSteps Financial first reported a position in Lexicon Pharmaceuticals in Q2 2023 and held it in 6 quarters.
LifeSteps Financial's Lexicon Pharmaceuticals position peaked at $24K in Q1 2024.
127 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q4 2024.

Based on LifeSteps Financial's 13F filing for Q4 2024, filed 3 Feb 2025.